Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Vyxeos

Drug Oncology

NDC 68727-745-01

Open in the dashboard

General payments

$1,413,711

2,893 payments

Research payments

$13,781,721

180 payments

Through program year 2019, $1,413,711 in general payments and $13,781,721 in research payments were reported against Vyxeos (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $1,413,711 2,893
2019 Research $13,781,721 180

Breakdown

Who paid General payments · program year 2019
  1. Jazz Pharmaceuticals Inc. $1,413,711 2,893 payments
Top recipients General payments · program year 2019
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $142,750 10% · 2 payments
  2. James McCloskey Medical Oncology · Hackensack, NJ $96,142 7% · 94 payments
  3. Hana Safah Hematology & Oncology · Baton Rouge, LA $67,442 5% · 71 payments
  4. Joseph Bailes McKinney, TX $56,254 4% · 7 payments
  5. Rami Komrokji Hematology · Tampa, FL $51,693 4% · 50 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $652,167 56% · 691 practitioners
  2. Medical Oncology Internal Medicine $295,404 26% · 172 practitioners
  3. Hematology Internal Medicine $123,608 11% · 53 practitioners
  4. Anatomic Pathology Pathology $25,528 2% · 2 practitioners
  5. Hematology Pathology $21,952 2% · 4 practitioners

The top 5 of 61 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Texas $279,223 20% · 156 recipients
  2. Ohio $129,413 9% · 57 recipients
  3. New Jersey $123,174 9% · 42 recipients
  4. New York $91,806 6% · 33 recipients
  5. Florida $69,319 5% · 75 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

2,893 general · 180 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record